Healthcare provider profile · identity verified

Addison G Haynes, DO

Family Practice · KOKOMO, IN · NPI 1295080620

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	348	101
Amlodipine Besylate	Amlodipine Besylate	241	66
Losartan Potassium	Losartan Potassium	232	65
Levothyroxine Sodium	Levothyroxine Sodium	214	56
Metformin Hcl	Metformin Hcl	167	47
Hydrochlorothiazide	Hydrochlorothiazide	150	46
Lisinopril	Lisinopril	149	40
Trulicity	Dulaglutide	137	25
Metoprolol Succinate	Metoprolol Succinate	112	28
Jardiance	Empagliflozin	109	32
Pantoprazole Sodium	Pantoprazole Sodium	107	40
Gabapentin	Gabapentin	100	29
Mounjaro	Tirzepatide	96	14
Tamsulosin Hcl	Tamsulosin Hcl	95	30
Omeprazole	Omeprazole	92	29
Sertraline Hcl	Sertraline Hcl	85	27
Escitalopram Oxalate	Escitalopram Oxalate	82	22
Duloxetine Hcl	Duloxetine Hcl	79	24
Rosuvastatin Calcium	Rosuvastatin Calcium	76	20
Buspirone Hcl	Buspirone Hcl	64	23
Montelukast Sodium	Montelukast Sodium	63	17
Carvedilol	Carvedilol	61	16
Fluticasone Propionate	Fluticasone Propionate	54	35
Ozempic	Semaglutide	53	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	12
Simvastatin	Simvastatin	49	14
Spironolactone	Spironolactone	48	15
Allopurinol	Allopurinol	47	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	45	14
Trazodone Hcl	Trazodone Hcl	43	11
Alendronate Sodium	Alendronate Sodium	41	15
Metoprolol Tartrate	Metoprolol Tartrate	40	13
Potassium Chloride	Potassium Chloride	40	16
Pregabalin	Pregabalin	40	suppressed
Metformin Hcl Er	Metformin Hcl	39	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Famotidine	Famotidine	34	19
Paroxetine Hcl	Paroxetine Hcl	34	12
Furosemide	Furosemide	33	19
Ramipril	Ramipril	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Irbesartan	Irbesartan	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Naproxen	Naproxen	27	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	15
Meloxicam	Meloxicam	24	16
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	16
Finasteride	Finasteride	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	20
Amoxicillin	Amoxicillin	19	18
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Azithromycin	Azithromycin	17	17
Benazepril Hcl	Benazepril Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Eliquis	Apixaban	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Atenolol	Atenolol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Cefadroxil	Cefadroxil	13	13
Prednisone	Prednisone	13	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Synjardy	Empagliflozin/Metformin Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error